Synthesis of citrate-ciprofloxacin conjugates

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 5, 2009, Pages 1496-1498

  Md Saleh, Siti R ^a   Chilvers, Emily C ^a   Kerr, Kevin G ^b,c   Milner, Stephen J ^a   Snelling, Anna M ^c   Weber, Jan P ^a   Thomas, Gavin H ^a   Duhme Klair, Anne Kathrin ^a   Routledge, Anne ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Ciprofloxacin; Citrate; Escherichia coli

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CITRATE CIPROFLOXACIN CONJUGATE; CITRIC ACID; OUTER MEMBRANE PROTEIN F; UNCLASSIFIED DRUG;

AMIDATION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BURKHOLDERIA CEPACIA; CELL TRANSPORT; CHEMICAL BOND; CONTROLLED STUDY; DRUG CONJUGATION; DRUG MECHANISM; DRUG SYNTHESIS; DRUG UPTAKE; ESCHERICHIA COLI K 12; GENE DELETION; INHIBITION KINETICS; NONHUMAN; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STEREOISOMERISM; WILD TYPE;

CIPROFLOXACIN; CITRIC ACID; ESCHERICHIA COLI K12; GENE DELETION; HUMANS; PORINS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ESCHERICHIA COLI; ESCHERICHIA COLI K12;

EID: 60449091061     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.01.007     Document Type: Article

References (26)

1. Schmitz F.-J., Verhoef J., and Fluit A.C. Int. J. Antimicrob. Agents 12 (1999) 311
2. Drlica K., and Zhao X. Microbiol. Mol. Biol. Rev. (1997) 377
3. Ruiz J. J. Antimicrob. Chemother. 51 (2003) 1109
4. Robicsek A., Jacoby G.A., and Hooper D.C. Lancet Infect. Dis. 6 (2006) 629
5. Hooper D.C., Wolfson J.S., Souza K.S., Ng E.Y., McHugh G.L., and Swartz M.N. Antimicrob. Agents Chemother. (1989) 283
6. Fernandes F., Neves P., Gameiro P., Loura L.M.S., and Prieto M. Biochim. Biophys. Acta 1768 (2007) 2822
7. Hirai H., Aoyama H., Irikura T., Iyobe S., and Mitsuhashi S. Antimicrob. Agents Chemother. (1986) 535
8. Ferguson A.D., Chakraborty R., Smith B.S., Esser D., van der Helm D., and Deisenhofer J. Science 295 (2002) 1658
9. Braun V., and Herrmann C. J. Bacteriol. (2007) 6918
10. Wagegg W., and Braun V. J. Bacteriol. 145 (1981) 156
11. Hussein S., Hantke K., and Braun V. Eur. J. Biochem. 117 (1981) 431
12. Gautier-Luneau I., Merle C., Phanon D., Lebrun C., Biaso F., Serratrice G., and Pierre J.-L. Chem. Eur. J. 11 (2005) 2207
13. Nikaido H., and Rosenberg E.Y. J. Bacteriol. 172 (1990) 1361
14. Siddiqui R., Sultana N., Khan K.M., Akbar N., Ali M., and Arayne S. J. Chin. Clinc. Med. 2 (2007) 188
15. Hennard C., Truong Q.C., Desnottes J.-F., Paris J.-M., Moreau N.J., and Abdallah M.A. J. Med. Chem. 44 (2001) 2139
16. Rivault F., Liebert C., Burger A., Hoegy F., Abdallah M.A., Schalk I.J., and Mislin G.L.A. Bioorg. Med. Chem. Lett. 17 (2007) 640
17. Guo H., Naser S.A., Ghobrial G., and Phanstiel IV O. J. Med. Chem. 45 (2002) 2056
18. Hirota K., Kitagawa H., Shimamura M., and Ohmori S. Org. Lett. (1980) 191
19. Koga H., Itoh A., Murayama S., Suzue S., and Irikura T. J. Med. Chem. 23 (1980) 1358
20. 9F 504.1418. Found 504.1424.
21. Strains were obtained from the culture collection of the Bradford Infection Group. Bacteria were harvested from overnight plates and suspended in sterile saline to McFarland turbidity standard 0.5. Suspensions were used to make confluent lawns of each strain on Iso-Sensitest agar (Oxoid Ltd). Sterile filter paper discs (0.6 cm diameter) were impregnated with 5 μg of ciprofloxacin stock or conjugate. Commercially available 5 μg ciprofloxacin discs (Oxoid) were also used to determine if strains were ciprofloxacin resistant, as defined by CLSI criteria. Discs were placed on the agar surface, and plates incubated for 18-20 h at 37 °C, and the diameter of zones of inhibition were then recorded.
22. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. CLSI M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
23. Baba T., Ara T., Hasegawa M., Takai Y., Okumura Y., Baba M., Datsenko K.A., Tomita M., Wanner B.L., and Mori H. Mol. Syst. Biol. 2 (2006) 2006.0008
24. Cultures of BW25113 and its isogenic ompF mutant grown aerobically in M9 minimal medium with either 1 mM or 1 μM ferric citrate were subcultured into 20 ml M9 medium with either 1 mM or 1 μM ferric nitrate and grown to mid-log phase, then harvested by centrifugation, and washed three times in M9. 120 μL of each culture was mixed with 7 mL bacteriological agar which was poured as an overlay on a bottom layer of M9 agar. 0.1 μg of ciprofloxacin or 0.15 μg of 1 were spotted on the surface of the plates and then the plates were incubated at 37 °C overnight before measuring the diameter of the zone of inhibition.
25. Selvin P.R., Jancarik J., and Hung L.-W. Inorg. Chem. 35 (1996) 700
26. Carrano C.J., Drechsel H., Kaiser D., Jung G., Matzanke B., Winkelmann G., Rochel N., and Albrecht-Gary A.M. Inorg. Chem. 35 (1996) 6429